---
title: "Bioxytran, Inc. (BIXT.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/BIXT.US.md"
symbol: "BIXT.US"
name: "Bioxytran, Inc."
industry: "Biotechnology"
---

# Bioxytran, Inc. (BIXT.US)

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Location | US Market |
| Website | [www.bioxytraninc.com](https://www.bioxytraninc.com) |

## Company Profile

Bioxytran, Inc., a clinical stage pharmaceutical company, focuses on the development, manufacture, and commercialization of therapeutic drugs to address hypoxia in humans. The company’s lead drug candidate is BXT-25, an oxygen-carrying small molecule consisting of bovine hemoglobin stabilized with a...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -2.15 | 263/604 | - | - | - |
| PB | -1.72 | 497/604 | - | - | - |
| Dividend Yield | 0.00% | - | - | - | - |

## References

- [Company Overview](https://longbridge.com/en/quote/BIXT.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/BIXT.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/BIXT.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.